<DOC>
	<DOCNO>NCT02203266</DOCNO>
	<brief_summary>The purpose trial discover whether provide feedback patient device record well patient us Seretide Diskus inhaler lead : - Improved compliance prescribe inhaler use - Improved technique inhaler use - A reduction respiratory health relate outcome cause poor inhaler compliance usage . - An improvement patient quality life score</brief_summary>
	<brief_title>Teaching Inhaler Use With INCA Device Community Pharmacy Setting</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Must 18 year old Capable understanding willing provide voluntary inform consent protocol specific procedure perform Capable understand comply requirement protocol , demonstrate willingness attend require visit . Able willing take inhaled medication . Have valid prescription use Seretide diskus inhaler already use Seretide diskus inhaler . Have history regular attendance pharmacy recruit demonstrated subject collect three prescription medication pharmacy six month preceeding recruitment study . Patient expressly report physician indicate continue receive Seretide next 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Medication Adherence</keyword>
	<keyword>Patient Compliance</keyword>
</DOC>